106 related articles for article (PubMed ID: 16379617)
1. Use of the next generation pharmaceutical impactor for particle size distribution measurements of live viral aerosol vaccines.
Leung K; Louca E; Gray M; Tipples G; Coates AL
J Aerosol Med; 2005; 18(4):414-26. PubMed ID: 16379617
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of methods to measure aerosols generated by a vibrating mesh nebulizer.
Waldrep JC; Berlinski A; Dhand R
J Aerosol Med; 2007; 20(3):310-9. PubMed ID: 17894537
[TBL] [Abstract][Full Text] [Related]
3. Comparison of nebulized particle size distribution with Malvern laser diffraction analyzer versus Andersen cascade impactor and low-flow Marple personal cascade impactor.
Kwong WT; Ho SL; Coates AL
J Aerosol Med; 2000; 13(4):303-14. PubMed ID: 11262437
[TBL] [Abstract][Full Text] [Related]
4. Optimization of a procedure used to measure aerosol characteristics of nebulized solutions using a cooled next generation impactor.
Berlinski A; Hayden JB
J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):397-404. PubMed ID: 20958142
[TBL] [Abstract][Full Text] [Related]
5. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer.
Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC
AAPS PharmSciTech; 2003 Oct; 4(4):E54. PubMed ID: 15198549
[TBL] [Abstract][Full Text] [Related]
6. Application of a droplet evaporation model to aerodynamic size measurement of drug aerosols generated by a vibrating mesh nebulizer.
Rao N; Kadrichu N; Ament B
J Aerosol Med Pulm Drug Deliv; 2010 Oct; 23(5):295-302. PubMed ID: 20455771
[TBL] [Abstract][Full Text] [Related]
7. Crossover Evaluation of Compressors and Nebulizers Typically Used by Cystic Fibrosis Patients.
Awad SM; Berlinski A
Respir Care; 2018 Mar; 63(3):294-300. PubMed ID: 29432139
[TBL] [Abstract][Full Text] [Related]
8. Determination of nebulizer droplet size distribution: a method based on impactor refrigeration.
Berg E; Svensson JO; Asking L
J Aerosol Med; 2007; 20(2):97-104. PubMed ID: 17536948
[TBL] [Abstract][Full Text] [Related]
9. In vitro estimations of in vivo jet nebulizer efficiency using actual and simulated tidal breathing patterns.
Bosco AP; Rhem RG; Dolovich MB
J Aerosol Med; 2005; 18(4):427-38. PubMed ID: 16379618
[TBL] [Abstract][Full Text] [Related]
10. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
[TBL] [Abstract][Full Text] [Related]
11. Effects of Temperature and Humidity on Laser Diffraction Measurements to Jet Nebulizer and Comparison with NGI.
Song X; Hu J; Zhan S; Zhang R; Tan W
AAPS PharmSciTech; 2016 Apr; 17(2):380-8. PubMed ID: 26169901
[TBL] [Abstract][Full Text] [Related]
12. Cooling the NGI - an approach to size a nebulised aerosol more accurately.
Dennis J; Berg E; Sandell D; Ali A; Lamb P; Tservistas M; Karlsson M; Mitchell J
Pharmeur Sci Notes; 2008 Feb; 2008(1):27-30. PubMed ID: 18430404
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical aspects and efficiency of albuterol nebulization: comparison of three aerosol types in an in vitro pediatric model.
Sidler-Moix AL; Di Paolo ER; Dolci U; Berger-Gryllaki M; Cotting J; Pannatier A
Respir Care; 2015 Jan; 60(1):38-46. PubMed ID: 25516995
[TBL] [Abstract][Full Text] [Related]
14. Output and aerosol properties of 5 nebulizer/compressor systems with arformoterol inhalation solution.
Bauer A; McGlynn P; Bovet LL; Mims PL; Curry LA; Hanrahan JP
Respir Care; 2009 Oct; 54(10):1342-7. PubMed ID: 19796414
[TBL] [Abstract][Full Text] [Related]
15. A new approach to characterise pharmaceutical aerosols: measurement of aerosol from a single dose aqueous inhaler with an optical particle counter.
Kuhli M; Weiss M; Steckel H
Eur J Pharm Sci; 2010 Jan; 39(1-3):45-52. PubMed ID: 19874891
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal evaluation of compressor/nebulizer performance.
Awad S; Williams DK; Berlinski A
Respir Care; 2014 Jul; 59(7):1053-61. PubMed ID: 24149670
[TBL] [Abstract][Full Text] [Related]
17. Influences of cannula size and flow rate on aerosol drug delivery through the Vapotherm humidified high-flow nasal cannula system.
Perry SA; Kesser KC; Geller DE; Selhorst DM; Rendle JK; Hertzog JH
Pediatr Crit Care Med; 2013 Jun; 14(5):e250-6. PubMed ID: 23628834
[TBL] [Abstract][Full Text] [Related]
18. Calculating expected lung deposition of aerosolized administration of AAV vector in human clinical studies.
Leung K; Louca E; Munson K; Dutzar B; Anklesaria P; Coates AL
J Gene Med; 2007 Jan; 9(1):10-21. PubMed ID: 17154340
[TBL] [Abstract][Full Text] [Related]
19. Characterization of aerosol output from various nebulizer/compressor combinations.
Reisner C; Katial RK; Bartelson BB; Buchmeir A; Rosenwasser LJ; Nelson HS
Ann Allergy Asthma Immunol; 2001 May; 86(5):566-74. PubMed ID: 11379809
[TBL] [Abstract][Full Text] [Related]
20. A methodology to study impactor particle reentrainment and a proposed stage coating for the NGI.
Rissler J; Asking L; Dreyer JK
J Aerosol Med Pulm Drug Deliv; 2009 Dec; 22(4):309-16. PubMed ID: 19415989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
